We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Review Increased Death Risk for Pfizer’s Zithromax
FDA to Review Increased Death Risk for Pfizer’s Zithromax
May 17, 2012
The FDA is reviewing a study that found patients treated with Pfizer’s antibiotic Zithromax may be at a slightly higher risk for cardiovascular death than those taking amoxicillin, Bayer Healthcare’s Cipro or no drug.